365 related articles for article (PubMed ID: 16026947)
1. The development of DMA for the detection of amorphous content in pharmaceutical powdered materials.
Royall PG; Huang CY; Tang SW; Duncan J; Van-de-Velde G; Brown MB
Int J Pharm; 2005 Sep; 301(1-2):181-91. PubMed ID: 16026947
[TBL] [Abstract][Full Text] [Related]
2. A novel powder sample holder for the determination of glass transition temperatures by DMA.
Mahlin D; Wood J; Hawkins N; Mahey J; Royall PG
Int J Pharm; 2009 Apr; 371(1-2):120-5. PubMed ID: 19167475
[TBL] [Abstract][Full Text] [Related]
3. Assessing the re-crystallization behaviour of amorphous lactose using the RH-perfusion cell.
Timmermann IL; Steckel H; Trunk M
Eur J Pharm Biopharm; 2006 Aug; 64(1):107-14. PubMed ID: 16527465
[TBL] [Abstract][Full Text] [Related]
4. Approaches to determine the enthalpy of crystallisation, and amorphous content, of lactose from isothermal calorimetric data.
Dilworth SE; Buckton G; Gaisford S; Ramos R
Int J Pharm; 2004 Oct; 284(1-2):83-94. PubMed ID: 15454300
[TBL] [Abstract][Full Text] [Related]
5. The potential of high speed DSC (hyper-DSC) for the detection and quantification of small amounts of amorphous content in predominantly crystalline samples.
Saunders M; Podluii K; Shergill S; Buckton G; Royall P
Int J Pharm; 2004 Apr; 274(1-2):35-40. PubMed ID: 15072780
[TBL] [Abstract][Full Text] [Related]
6. Determination of low levels of amorphous content in inhalation grade lactose by moisture sorption isotherms.
Vollenbroek J; Hebbink GA; Ziffels S; Steckel H
Int J Pharm; 2010 Aug; 395(1-2):62-70. PubMed ID: 20493937
[TBL] [Abstract][Full Text] [Related]
7. Influence of amorphous content on compaction behaviour of anhydrous alpha-lactose.
Ziffels S; Steckel H
Int J Pharm; 2010 Mar; 387(1-2):71-8. PubMed ID: 20005927
[TBL] [Abstract][Full Text] [Related]
8. Calorimetric determination of amorphous content in lactose: a note on the preparation of calibration curves.
Ramos R; Gaisford S; Buckton G
Int J Pharm; 2005 Aug; 300(1-2):13-21. PubMed ID: 16009516
[TBL] [Abstract][Full Text] [Related]
9. Determination of amorphous content in the pharmaceutical process environment.
Savolainen M; Jouppila K; Pajamo O; Christiansen L; Strachan C; Karjalainen M; Rantanen J
J Pharm Pharmacol; 2007 Feb; 59(2):161-70. PubMed ID: 17270070
[TBL] [Abstract][Full Text] [Related]
10. Supercritical fluid drying of carbohydrates: selection of suitable excipients and process conditions.
Bouchard A; Jovanović N; Hofland GW; Jiskoot W; Mendes E; Crommelin DJ; Witkamp GJ
Eur J Pharm Biopharm; 2008 Mar; 68(3):781-94. PubMed ID: 17702554
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of amorphous content of lactose using CCD-Raman spectroscopy.
Niemelä P; Päällysaho M; Harjunen P; Koivisto M; Lehto VP; Suhonen J; Järvinen K
J Pharm Biomed Anal; 2005 Apr; 37(5):907-11. PubMed ID: 15862665
[TBL] [Abstract][Full Text] [Related]
12. Crystallization and X-ray diffraction of spray-dried and freeze-dried amorphous lactose.
Haque MK; Roos YH
Carbohydr Res; 2005 Feb; 340(2):293-301. PubMed ID: 15639249
[TBL] [Abstract][Full Text] [Related]
13. Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers.
Corrigan DO; Corrigan OI; Healy AM
Int J Pharm; 2006 Sep; 322(1-2):22-30. PubMed ID: 16815654
[TBL] [Abstract][Full Text] [Related]
14. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
Marriott C; MacRitchie HB; Zeng XM; Martin GP
Int J Pharm; 2006 Dec; 326(1-2):39-49. PubMed ID: 16942848
[TBL] [Abstract][Full Text] [Related]
15. Lactose/beta-lactoglobulin interaction during storage of model whey powders.
Thomas ME; Scher J; Desobry S
J Dairy Sci; 2004 May; 87(5):1158-66. PubMed ID: 15290962
[TBL] [Abstract][Full Text] [Related]
16. Quantification of low levels of amorphous content in sucrose by hyperDSC.
Lappalainen M; Pitkänen I; Harjunen P
Int J Pharm; 2006 Jan; 307(2):150-5. PubMed ID: 16288841
[TBL] [Abstract][Full Text] [Related]
17. Predicting the physical state of spray dried composites: salbutamol sulphate/lactose and salbutamol sulphate/polyethylene glycol co-spray dried systems.
Corrigan DO; Corrigan OI; Healy AM
Int J Pharm; 2004 Apr; 273(1-2):171-82. PubMed ID: 15010141
[TBL] [Abstract][Full Text] [Related]
18. Determining the critical relative humidity for moisture-induced phase transitions.
Burnett DJ; Thielmann F; Booth J
Int J Pharm; 2004 Dec; 287(1-2):123-33. PubMed ID: 15541919
[TBL] [Abstract][Full Text] [Related]
19. Effect of milling conditions on the solid-state conversion of ranitidine hydrochloride form 1.
Chieng N; Zujovic Z; Bowmaker G; Rades T; Saville D
Int J Pharm; 2006 Dec; 327(1-2):36-44. PubMed ID: 16949221
[TBL] [Abstract][Full Text] [Related]
20. Characterization of carbohydrate-protein matrices for nutrient delivery.
Zhou Y; Roos YH
J Food Sci; 2011 May; 76(4):E368-76. PubMed ID: 22417357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
